EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Metabolomics and Cardiovascular Risk in Patients with Heart Failure: A Systematic Review and Meta-Analysis

Leonel Sousa Neves, Francisca Saraiva iD, Rita Ferreira iD, Adelino Leite-Moreira iD, António S Barros iD, Sílvia O Diaz iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25115693 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Leonel Sousa Neves und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular R&D Centre, UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal. Hauptthemen laut MEDLINE: Heart Failure, Metabolomics. Die Arbeit wurde bisher 17-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, FCT—Portuguese Foundation for Science and Technology, Cardiovascular R&D Center—UnIC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The associations of plasma metabolites with adverse cardiovascular (CV) outcomes are still underexplored and may be useful in CV risk stratification. We performed a systematic review and meta-analysis to establish correlations between blood metabolites and adverse CV outcomes in patients with heart failure (HF). Four cohorts were included, involving 83 metabolites and 37 metabolite ratios, measured in 1158 HF patients. Hazard ratios (HR) of 42 metabolites and 3 metabolite ratios, present in at least two studies, were combined through meta-analysis. Higher levels of histidine (HR 0.74, 95% CI [0.64; 0.86]) and tryptophan (HR 0.82 [0.71; 0.96]) seemed protective, whereas higher levels of symmetric dimethylarginine (SDMA) (HR 1.58 [1.30; 1.93]), N-methyl-1-histidine (HR 1.56 [1.27; 1.90]), SDMA/arginine (HR 1.38 [1.14; 1.68]), putrescine (HR 1.31 [1.06; 1.61]), methionine sulfoxide (HR 1.26 [1.03; 1.52]), and 5-hydroxylysine (HR 1.25 [1.05; 1.48]) were associated with a higher risk of CV events. Our findings corroborate important associations between metabolic imbalances and a higher risk of CV events in HF patients. However, the lack of standardization and data reporting hampered the comparison of a higher number of studies. In a future clinical scenario, metabolomics will greatly benefit from harmonizing sample handling, data analysis, reporting, and sharing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureMetabolomicsHumansBiomarkersCardiovascular DiseasesMetabolomeHeart Disease Risk Factors

Stichwörter der Autor:innen

biomarkerscardiovascular diseaseheart failuremetabolomicsprognosis

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Cardiovascular R&D Centre, UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.
  • LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal.

ORCID-Profile: Francisca Saraiva, Rita Ferreira, Adelino Leite-Moreira, António S Barros, Sílvia O Diaz

Förderung

  • Fundação para a Ciência e Tecnologia
  • FCT—Portuguese Foundation for Science and Technology
  • Cardiovascular R&D Center—UnIC
  • RISE
  • CardioNIR

Zitieren

APA

Neves, L. S., Saraiva, F., Ferreira, R., Leite-Moreira, A., Barros, A. S., & Diaz, S. O. (2024). Metabolomics and Cardiovascular Risk in Patients with Heart Failure: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25115693

Vancouver

Neves LS, Saraiva F, Ferreira R, Leite-Moreira A, Barros AS, Diaz SO. Metabolomics and Cardiovascular Risk in Patients with Heart Failure: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25115693

BibTeX
@article{Neves2024,
  author = {Neves, Leonel Sousa and Saraiva, Francisca and Ferreira, Rita and Leite-Moreira, Adelino and Barros, António S and Diaz, Sílvia O},
  title = {Metabolomics and Cardiovascular Risk in Patients with Heart Failure: A Systematic Review and Meta-Analysis},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25115693}
}
Kostenlos starten →